Methylmalonic Acid (MMA)

The cutoff most US labs use sits near 0.40 µmol/L, so a result of 0.45 prints as a flag while a 0.30 prints clean. The value matters less than the company it keeps. A mildly raised MMA in a 78-year-old with reduced kidney clearance reads very differently from the same number in a healthy 30-year-old, which is the caution the next sections keep returning to.

A high MMA almost always means one of two things, and telling them apart is most of the interpretive work.

The first, and the reason the test is usually ordered, is functional B12 deficiency: the cells cannot get enough B12 to keep methylmalonyl-CoA mutase running, so MMA backs up. What makes this useful is that it can be true while the serum B12 number still looks fine. Serum B12 counts everything circulating, including the large share bound to a carrier the cells can't easily use, so the headline figure can read normal over cells that are genuinely short. MMA reports from inside the reaction itself, which is why it is widely described as the most sensitive lab marker of B12 status. A raised MMA in someone with a low-normal B12 is strong evidence the deficiency is real at the cellular level.

The second is kidney clearance, and it is the honest caveat this test carries. MMA leaves the body through the kidneys, so when filtration falls, MMA rises whether or not B12 is short. The NIH notes that MMA can be elevated in renal insufficiency, which means a high MMA in someone with impaired kidneys cannot be read as a clean B12 signal. This is why a raised result is often weighed against a kidney marker such as creatinine before any conclusion about B12 is drawn. Age compounds it from both ends, since B12 absorption tends to slip and kidney function tends to decline, so MMA drifts upward with age for reasons that aren't always about diet.

A few other things nudge MMA up by lowering B12 over time rather than directly: long-term metformin, the acid-suppressing drugs (proton-pump inhibitors and H2 blockers), gastric or small-bowel surgery, and strict plant-only eating without a supplement. Rare inherited disorders of MMA metabolism produce strikingly high values, but those declare themselves early in life.

Why MMA beats homocysteine at this one job

When a borderline B12 needs confirming, two by-products can be checked, and the difference between them is the point. Homocysteine rises when either B12 or folate is low, and reduced kidney function, an underactive thyroid, and a handful of drugs move it as well. That breadth makes it sensitive but blunt: a high homocysteine signals that something in the B-vitamin machinery is lagging without naming which part. MMA is narrow by comparison. Setting kidney clearance aside, it climbs essentially only when B12 is the missing handler, because folate plays no role in the methylmalonyl-CoA step.

That single difference is what lets the pair sort a confusing result. A normal MMA with a high homocysteine points toward folate; both raised points back at B12; a raised MMA settles the B12 question more firmly than homocysteine can on its own. The homocysteine and B12 comparison walks through how the two metabolites split the diagnostic work, and folate covers the deficiency MMA is built to rule out.

Low MMA is the result you want and the one almost nobody asks about, which is why most labs print no lower flag at all. A low or low-normal value simply means the carousel is clearing efficiently: cells have the B12 they need to run the step, so nothing accumulates. There is no recognized disease of "too little MMA"; the test was built to catch a buildup, not a shortfall.

MMA rarely opens a case; it closes one. It sits on the vitamins and nutrients panel as the confirming read for B12, the test you reach for once the serum number raises a question it can't answer alone. When anemia is in the picture, a raised MCV and the rest of the red-cell indices fill in whether the shortage has reached the marrow, and the vitamin panel guide reads the whole set together.

Because MMA moves on the timescale of treatment, often falling within weeks once a true B12 shortage is corrected, the question is usually how soon to recheck it rather than what a single value proves. An MMA of 0.45 means one thing if last month's was 0.70 and falling on B12, and something else if it was 0.30 and climbing, read in motion against the B12 and kidney numbers standing beside it.